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Abstract
Background Home telehealth has the potential to benefit heart
failure (HF) and chronic obstructive pulmonary disease (COPD)
patients, however large-scale deployment is yet to be achieved.
Purpose The aim of this review was to assess levels of uptake
of home telehealth by patients with HF and COPD and the
factors that determine whether patients do or do not accept and
continue to use telehealth.
Methods This research performs a narrative synthesis of the
results from included studies.
Results Thirty-seven studies met the inclusion criteria. Stud-
ies that reported rates of refusal and/or withdrawal found that
almost one third of patients who were offered telehealth
refused and one fifth of participants who did accept later
abandoned telehealth. Seven barriers to, and nine facilitators
of, home telehealth use were identified.
Conclusions Research reports need to provide more details
regarding telehealth refusal and abandonment, in order to
understand the reasons why patients decide not to use
telehealth.
Keywords Telehealth . HF . COPD . Systematic review .
Uptake
Background
Heart failure (HF) and chronic obstructive pulmonary disease
(COPD) place considerable burden on patients and healthcare
systems through repeated emergency department visits and
lengthy hospital admissions [1, 2]. The incidence of HF and
COPD is increasing [3–5], and the associated costs are sub-
stantial. In 2012, the combined total annual direct cost of HF
and COPD in the USAwas estimated to be over $50 billion [6,
7]. Furthermore, HF and COPD patients report significant
impairments in their physical and social functioning [8–11].
Quality of life among patients with HF and COPD is signif-
icantly lower than that of the general population [12–14] and
that of patients with other chronic diseases [9, 15, 16]. As the
population ages and the incidence of HF and COPD escalates,
it has been suggested that telehealth may become the only
cost-effective means of maintaining and enhancing the quality
of care [17–19].
Telehealth is a comprehensive concept that encompasses the
transfer and exchange of health information through electronic
devices. The focus of the present review is home telehealth,
which involves the remote delivery of health-related services via
information and communication technologies between a patient
and healthcare professionals, to assist in the monitoring and
management of a patient’s health condition [20, 21]. The review
will not focus on mobile phone-based telehealth interventions,
because at present mobile-based systems are not a main-
stream means of delivering telehealth to HF and COPD
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patients. Compared with traditional approaches, telehealth
may deliver enhanced care to HF and COPD patients by
providing early warning of health status deterioration, thereby
avoiding negative health outcomes [19, 22–24]. Telehealth
may also reduce costs by decreasing rehospitalization rates
[25, 26]. Previous systematic reviews have indicated that
compared with usual care, telehealth shows benefits in terms
of reduced emergency department visits, hospital admis-
sions, and mortality rates, enhanced quality of life, and
improvements in patient knowledge and self-care
[27–29], although some recent large studies have not
shown such benefit [21, 30, 31].
Despite mixed evidence of benefit, there is a strong policy
push to introduce telehealth in the UK and Europe. The UK
Department of Health believes that telehealth and telecare
(services that enable people to live independently and securely
in their own homes) could benefit the lives of at least three
million people with long-term conditions and/or social care
needs. The rationale is that, if implemented effectively as part
of a whole system redesign of care, then telehealth and
telecare can ease pressure on long-term UK National Health
Service costs and improve people’s quality of life through
enhanced self-care in the home environment [32]. Large-
scale deployment of telehealth in the UK or in Europe is,
however, yet to be achieved.
Patient acceptance has been identified as one of the most
important influences on the future implementation of
telehealth [33], and there is a perception that many patients
refuse or quickly abandon telehealth [34, 35]. Despite this, the
proportion of patients who refuse or abandon telehealth is
largely unknown. Research is needed to quantify the rates of
patient uptake, refusal, and abandonment of telehealth, to
understand the number of patients who are willing to
accept and use it. Research also needs to explore patient
beliefs and perceptions about telehealth to try and ex-
plain why patients decide to take up, refuse, abandon,
or sustain their use of telehealth.
A systematic review was undertaken to consolidate current
knowledge on: (a) the rates of uptake, refusal, and abandon-
ment of home telehealth by patients with HF or COPD, and
(b) the factors that influence whether patients with HF or
COPD do or do not accept and use telehealth.
Methods
The review was conducted in accordance with the Cochrane
guidelines for systematic reviews [36].
Search Strategy
The following databases were searched for relevant studies
published without date limits up to the date of the search
(September 2013): the Cochrane CENTRAL Register of Con-
trolled Trials, Cumulative Index to Nursing and Allied Health
Literature, MEDLINE, PsycInfo, and the ISI Web of
Knowledge/Science/Conference Proceedings Citation Index.
To be as comprehensive as possible, it was necessary to
include a wide range of free-text terms for each of the con-
cepts. The following population search terms were used:
“Heart Failure” OR “HF” OR “Chronic Obstructive Pulmo-
nary Disease” OR “COPD.” The following intervention
search terms were used: “telehealth” OR “telemedicine” OR
“telecare” OR “telehomecare” OR “telemonitoring” OR
“telemanagement” OR “teleconsultation” OR “telecommuni-
cations” OR “remote consultation” OR “remote monitoring”
OR “assistive technology” OR “ehealth” OR “telenursing.”
The following outcome terms were used: “uptake” OR
“adoption” OR “refusal” OR “abandon*” OR “accept*”
OR “embrace” OR “reject*” OR “decline” OR “beliefs”
OR “perceptions” OR “facilitators” OR “barriers” OR
“obstacles” OR “challenges” OR “sustained use” OR
“maintenance.” Hand-searching reference lists of other
systematic review articles was also conducted [21,
27–29], as research has found this method to be valu-
able in identifying studies for inclusion in systematic
reviews of healthcare [37]. General Web searching was
not conducted, as there is little empirical evidence as to
the value of using general Internet search engines to
identify potential studies [38]. All lists of citation re-
sults were generated and exported into MENDELEY
(Mendeley, Ltd. London, UK, www.mendeley.com).
Inclusion and Exclusion Criteria
A study was eligible for inclusion if it described an interven-
tion that specifically utilized technology as a means of deliv-
ering healthcare to patients with a diagnosis of HF and/or
COPD in their own homes or in a residential care home.
Telehealth had to be a core component of the intervention.
Interventions used by the patient with no interaction or input
from a health professional or facilitator were excluded. Tech-
nology using mobile phone-based interventions was also ex-
cluded, as the focus of the review was home telehealth.
Studies were included in the review if they mentioned any
details relating to patient acceptance, abandonment, or per-
ceptions of telehealth. Randomized controlled trials, correla-
tional survey research, and observational research were eligi-
ble for inclusion. Published conference proceedings were
included where sufficient data were provided on population,
intervention, and outcomes. Nonprimary research and disser-
tations were excluded. HF and/or COPD patients confirmed
bymedical records or by medical practitioner were eligible for
inclusion. Hospitalized patients and those with acute exacer-
bations of symptoms were excluded. Participants had to be
aged 18 years or above. Data to be extracted for HF and/or
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COPD patients had to be presented in isolation from patients
with a different diagnosis (see Table 1).
Review Procedure
Two members of the study team (SLG and CJA) independent-
ly screened the titles and abstracts. Full papers were obtained
if either reviewer did not exclude the paper based on the
abstract or title. Full texts of papers were obtained and read
by one author (SLG). The relevance of each study was
assessed according to the predefined inclusion criteria.
Data Extraction
Data from the included studies were extracted by author SLG
into a data extraction sheet prepared for this study (see Elec-
tronic Supplementary Material (ESM) 1) and checked for
accuracy by author SB.
Data Analysis
A narrative synthesis of the data, primarily in terms of study
design, population, type of intervention, rates of uptake,
refusal, and abandonment and barriers to, and facilitators of,
acceptance and sustained use of telehealth, was carried out
(ESM 2). Thematic analysis was used to identify the most
important and recurrent themes relating to the barriers and
facilitators across the multiple studies. The analysis was de-
veloped in an inductive manner, without a set of a priori
themes to guide data extraction and analysis.
Thematic Analysis
Themes were separated into two categories: Those aspects of
the intervention that were judged to act as barriers to telehealth
and those aspects of the intervention that were judged to act as
facilitators of telehealth. Barriers were defined as any negative
factors that may lead to patients declining or abandoning
telehealth. Facilitators were defined as any positive factors
that may lead to patients deciding to take up or sustain using
telehealth. There needed to be multiple (≥2) occurrences of
positive or negative details within and between papers, in
order for them to be considered a barrier or facilitator. To gain
insight into patient perceptions of the barriers to and facilita-
tors of telehealth acceptance and adherence, the themes were
listed in two tables, linking the barriers and facilitators with
Table 1 Study inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
Type of studies
Randomized controlled trials, correlational survey research and
observational research
Commentaries, editorials and expert opinion, literature and
systematic reviews, letters, and other nonprimary research
Published conference proceedings, where sufficient data was provided
on population, intervention, and outcomes
Dissertations and papers written in non-English language
Types of participants
HF and/or COPD patients confirmed by medical records or by medical
practitioner
Hospitalized patients and those with acute exacerbations
of symptoms
Living at home or in a residential care home
Aged 18 years or above
Data to be extracted presented for HF and/or COPD patients in isolation
from data from patients with a different diagnosis
Types of interventions
Utilized technology as a means of delivering healthcare to patients with
a diagnosis of HF and/or COPD in their own homes
Interventions with no interaction or input from a health
professional or facilitator
Technology had to be electronic and use either POTS (plain old
telephone service) or broadband connection
Interventions using telecommunication technologies primarily
for educational or administrative purposes and not linked to
direct patient care
Health or care involved healthcare delivery, education, advice that
involved a healthcare provider/professional within data transfer
Technology using mobile phone-based interventions
Telehealth had to be a core component of the intervention Interactions at GP practices or hospitals/clinical settings,
residential homes, prisons, or other institutionsPoints of healthcare delivery were limited to: home, sheltered housing,
extra care, and nursing home
Types of outcome measures
Any details relating to patients acceptance, abandonment, or
perceptions of telehealth
HF heart failure, COPD chronic obstructive pulmonary disease, GP general practitioner
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the studies in which they were reported. From these tables, it
was possible to see which barriers and facilitators were report-
ed most frequently. Rather than categorizing themes separate-
ly for HF and COPD patients, they were combined into a
single category, as several previous studies have combined the
results for HF and COPD patients regarding the impact and
perceptions of telehealth [19, 22, 39]. “Ideas Webbing”
was used to conceptualize and explore connections
among the themes. This approach uses figures/diagrams
to develop a visual picture of possible relationships
across study results [40].
Assessment of Methodological Quality
Methodological quality of studies was not used as an inclusion
criterion for the review, due to the diversity in study design
[41] and because the focus of the review was on patient
perceptions of the intervention as opposed to the effectiveness
of the intervention per se. Excluding studies based on quality
would have limited understanding of this objective. This
thematic analysis consequently reflects a purposeful decision
to deviate from focusing on methodological quality as a
criterion for inclusion. Nevertheless, giving equal weighting
to studies of good rigor and those with methodological flaws
could lead to drawing out inappropriate conclusions, so the
quality of papers and their impact has been commented upon
in accordance with the Critical Appraisal Skills Program
critical appraisal checklists, which covered rigor, credibility,
and relevance. Studies were rated independently by one author
(SLG) and checked by a second author (SB). A total method-
ological quality score was calculated for all papers. Studies
scoring in the 75th percentile or higher on quality were cate-
gorized as “high-quality” studies. Studies scoring between 50
and 75 % were rated as “moderate quality.” Studies scoring
lower than 50 % were considered “low quality” [42].
Results
Study Selection
The initial cross-database search yielded 824 articles (Fig. 1).
In total, 169 articles were immediately excluded, for reasons
including duplication and type of article (e.g., dissertations,
editorials, and systematic reviews). The titles and abstracts of
655 articles were screened (by SLG and CJA) and 556 were
excluded, as they did not meet the inclusion criteria. Full texts
were obtained for 99 articles, of which 58 were excluded
(ESM 3). The most common reasons for exclusion at this
stage were: data for HF and/or COPD patients were not
presented in isolation; no details on acceptance or abandon-
ment; or lack of detail on patient perceptions. This resulted in
a total of 41 articles [19, 22–24, 43–79] describing 37
individual studies, being eligible for inclusion in the review
(ESM 4).
Characteristics of Selected Studies
Of the 37 studies that met the inclusion criteria, 13 were
randomized controlled trials (RCT: [43, 45, 46, 49, 58,
60–63, 67, 69, 73, 74, 78]), nine employed mixed methods
[19, 24, 47, 52, 53, 55, 56, 64, 70, 71, 77], eight were
qualitative [22, 23, 44, 54, 57, 59, 66, 76], and seven were
cohort studies [48, 50, 51, 65, 68, 72, 75, 79] (see ESM 5 for
definitions of study designs).
Characteristics of Study Populations
Of the 37 studies, 22 included patients with HF only, 11
included patients with COPD only, and 4 studies included
patients with both HF and COPD. The number of study
participants ranged from 4 to 420 with an overall mean of
78 participants and amedian of 50 (37 studies). The number of
participants provided with telehealth, or whose percep-
tions of telehealth were assessed, ranged from 4 to 195
with an overall mean of 51 participants and a median of
30 (37 studies) (ESM 4). Descriptions of study populations
were not always comprehensive. Mean percentages have been
calculated and presented from studies with the available data.
The mean age of all participants was 65 years (30 studies: [19,
22–24, 43–47, 49–51, 54–57, 61–63, 65–69, 72–76, 78, 79]);
the mean age for participants offered telehealth was 68 years
(28 studies: [19, 22–24, 43–47, 50, 51, 54–57, 61, 62, 65–69,
72–76, 78, 79]). Thirty-one studies reported the gender of the
total sample (mean 62 % men and 38 % women: [19, 22, 24,
43–48, 50, 51, 54–57, 60–63, 65–69, 71–76, 78, 79]); thirty
studies recorded an average of 59 % men (41 % women)
offered telehealth [19, 22, 24, 43–48, 50, 51, 54–57, 60–62,
65–69, 71–76, 78, 79]. Regarding ethnicity, 56 % of the total
samples were white and 58 % of people offered telehealth
were white (11 studies: [22, 24, 45, 48, 55, 61, 66–68, 73,
74]). In terms of living situation, 66% of the total sample were
residing with their spouse, partner, relative, or caregiver and
34%were living alone (12 studies: [19, 22, 24, 45, 47–49, 57,
62, 67, 71, 78]). Similarly, 64 % of people offered telehealth
were residing with their spouse, partner, relative, or caregiver
and 36%were living alone (11 studies: [19, 22, 24, 45, 47, 48,
57, 62, 67, 71, 78]). Ten studies provided education details for
participants, and found the majority of both the total sample
and those offered telehealth to be high school educated or
above (62 and 67 %, respectively: [22, 45, 48, 55, 60, 65–67,
73, 78]).
Out of the 22 studies that included patients with HF only
and the 4 studies that included patients with both HF and
COPD, 16 studies reported details about the health status of
participants. Thirteen studies reported details about the
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average stage of HF for all participants, ranging from mild
(four studies: [49, 51, 65, 74]) to moderate (nine studies: [22,
45, 47, 48, 55, 66, 68, 69, 73]). Twelve studies reported details
about the average stage of HF for telehealth participants only:
the reported stages were mild (two studies: [51, 65]), moderate
(nine studies: [22, 47, 48, 55, 66, 68, 69, 73, 74]), and severe
(one study: [45]). Out of the 11 studies that included patients
with COPD only and the 4 studies that included patients with
both HF and COPD, 9 studies reported details about the
average COPD severity grade of all participants and telehealth
participants only. The reported grades were: mild (one study:
[44]), moderate (one study: [57]), and severe (seven studies:
[43, 46, 52, 53, 62, 67, 75, 76]). Twelve of the 37 included
studies reported no details about the health status of partici-
pants [19, 23, 24, 54, 56, 59, 60, 64, 71, 72, 77, 78].
Intervention Characteristics
All of the 37 studies included in the review featured either an
intervention, a demonstration of a telehealth device, or patient
interviews discussing perceptions of a telehealth intervention.
The interventions included: Remote monitoring and transmis-
sion of physiological data, assessment of health symptoms,
nurse telephone contact or video consultation, disease specific
education, health questions, and reinforcement of self-
management behaviors (ESM 4).
Participant Recruitment
Recruitment context varied across the included studies. Par-
ticipants were recruited from hospitals and/or medical centers
(14 studies: [19, 23, 43–46, 50, 51, 58, 60, 61, 69, 72, 74, 75,
78]), healthcare systems or databases (4 studies: [49, 52, 53,
62, 68, 70]), HF units/clinics (3 studies: [24, 65, 79]), and a
Medicare Coordinated Care Demonstration project (1 study:
[66]). Eight studies recruited patients who were already using
or had previously used some form of telehealth service [22,
47, 48, 54, 57, 59, 71, 76]. Another study recruited partici-
pants through recruitment announcements that were sent to
email distribution lists and online support groups for COPD
patients [67]. The recruitment context for six of the studies
was not stated [55, 56, 63, 64, 73, 77].
Records identified through database 
searching
(n = 794)
Sc
re
en
in
g
In
cl
ud
ed
E
lig
ib
ili
ty
Id
en
ti
fi
ca
ti
on Additional records identified 
through other sources
(n = 30)
Records after duplicates removed
(n = 655)
Records screened
(n = 655)
Records excluded
(n = 556)
Full-text articles assessed 
for eligibility
(n = 99)
Full-text articles excluded, 
with reasons
(n = 58)
Studies included in 
qualitative synthesis
(n = 37, 41 articles)
Studies included in 
quantitative synthesis 
(meta-analysis)
(n = 0)
Fig. 1 PRISMA 2009 flow
diagram
ann. behav. med. (2014) 48:323–336 327
Participant Refusals
Eight studies reported participant refusal rates for those of-
fered telehealth only, (see Table 2). On average, the studies
reported that 32 % (range, 4–71 %) of participants refused
telehealth [45, 48, 50, 51, 61, 63, 65, 68, 72]. Five out of the
eight studies provided reasons for refusal, with the most
common reasons being: Participants not interested and/or
believing monitoring to be unnecessary [45, 50, 51, 61, 65,
72]. Three studies reported some demographic information for
refusers: Mean age ranged from 68 to 70 years, females
accounted for 31 to 53 %, 88 % of refusers were white,
45 % were married, and 80 % were classified in New York
Heart Association functional class II [50, 51, 61, 72].
Participant Withdrawals
Twenty-one studies reported participant withdrawals from the
study, relating to people offered telehealth only (see Table 2).
On average, the studies reported that 20 % (range, 4–55 %) of
participants who agreed to participate subsequently withdrew
[19, 22, 43, 45–47, 49–51, 58, 60–63, 65, 67, 69, 72–75, 78,
79]. Fourteen out of the 21 studies provided reasons for
withdrawal, with the most common reasons being: Partici-
pants not wanting to use the telehealth device; health deterio-
ration; and technical problems [19, 22, 43, 46, 47, 49–51, 58,
60–63, 65, 67, 75]. One of the 21 studies reported details
about demographics and found people who withdrew had a
mean age of 54 years, 100 % were male, 67 % were married,
and 67 % were classified in New York Heart Association
functional class II [65].
Patient Barriers to Telehealth
Patient barriers to telehealth were reported in 17 studies (ESM
6: [19, 22–24, 44, 47, 49, 54, 56, 59, 67, 69, 71–73, 76, 79]).
Seven individual barriers were recorded: Technical problems,
believing telehealth to be unnecessary, preference for in-
person care, technology anxiety, difficulty remembering to
interact with system, need for technical support, and finding
telehealth to be a repetitive process (see Table 3).
Patient Facilitators of Telehealth
Patient facilitators of telehealth were reported in 29 studies
(ESM 7: [19, 22–24, 43–61, 64–68, 70, 71, 73, 76, 77]). Nine
individual facilitators were recorded: Improved self-care, in-
creased access to healthcare, improved health knowledge,
ease of use, peace of mind, convenience, effective health
management, appreciation of telehealth nurses, and believing
telehealth to be as good or better than in-person care (see
Table 4).
Appraising the Quality of Evidence
According to the quality criteria applied, 11 studies were
classified as high quality, 23 were categorized as moderate
quality, and three were classified as low quality (ESM 4). One
high-quality study reported a refusal rate for telehealth partic-
ipants only, with 48 % declining to participate [72]. Seven
moderate-quality studies reported refusal rates for telehealth
participants only, with an average of 31 % (range, 4–71 %)
refusing telehealth [45, 48, 50, 51, 61, 63, 65, 68]. One high-
quality and four moderate-quality studies provided reasons for
participant refusals [45, 50, 51, 61, 65, 72]. Demographics for
refusals were provided by one high-quality and two moderate-
quality studies [50, 51, 61, 72]. Six high-quality studies re-
ported participant withdrawals from the study, with an average
of 20 % (range, 4–48 %) of participants who agreed to
participate subsequently withdrawing [22, 47, 69, 72–74].
Fifteen moderate-quality studies reported participant with-
drawals from the study, with an average of a 23 % (range,
5–55 %) withdrawal rate [19, 43, 45, 46, 49–51, 58, 60–63,
65, 67, 75, 78, 79]. Two high-quality and 12 moderate-quality
studies provided reasons for participant withdrawal [19, 22,
43, 46, 47, 49–51, 58, 60–63, 65, 67, 75]. One moderate-
quality study provided demographics for withdrawals [65].
The most frequently reported barriers to telehealth accep-
tance in the high-quality papers were: Technical problems [47,
54, 69, 76]; and believing telehealth to be unnecessary [22, 47,
72, 73]. Among the moderate-quality papers, the most fre-
quently reported barriers to telehealth acceptance were: Tech-
nical problems [19, 49, 56, 67, 71, 79]; and preference for in-
person [19, 24, 49]. The most frequently reported facilitators
of telehealth acceptance reported in the high-quality papers
were: Improved self-care [22, 23, 54, 57, 66, 73, 76], im-
proved health knowledge [22, 23, 47, 54, 57, 73], and effec-
tive health management [22, 23, 47, 54, 57, 76]. Among the
moderate-quality papers, the most frequently reported facili-
tators of telehealth acceptance were: Improved self-care [24,
43, 48–53, 55, 56, 61, 65, 67, 68, 77] and increased access to
healthcare [19, 24, 45, 48, 49, 52, 53, 60, 65, 68, 77].
Discussion
The aims of the review were to assess the levels of uptake and
sustained use of home telehealth and to identify the factors
that influence whether patients with a diagnosis of HF or
COPD accept or refuse and sustain using or abandon
telehealth. Overall, studies reported that almost one third of
the patients who were eligible to receive telehealth refused to
participate and one fifth of patients who agreed to take part in
the studies later withdrew their consent. Studies showed a
wide range of both refusals (4–71 %) and withdrawals (4–
55 %). Twenty-one studies reported participant withdrawals
328 ann. behav. med. (2014) 48:323–336
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from the study, relating to people offered telehealth only,
however only eight studies reported participant refusal rates,
therefore levels reported in this reviewmay not be reflective of
the whole picture, owing to the small sample. Five out of eight
studies documented reasons for refusals to participate and 14
out of 21 studies provided reasons for participant withdrawals.
However, study reports did not go into great detail, meaning
that caution is warranted in interpreting these reports as accu-
rate accounts of participants’ reasons for refusing or with-
drawing. Limited details were provided regarding the demo-
graphics of patients who refused to participate, or withdrew.
Although 23 studies commented on participant refusals and/or
withdrawals, only four studies provided some form of demo-
graphic data for these participants. From the data provided by
these studies it appeared that there were very few differences
in relation to the age and gender of people who refused
compared with participants who accepted. However, only
one study reported details about the demographics of the
participants who withdrew, meaning it is difficult to draw
any comparisons between the participants who accepted a
telehealth intervention and those who withdrew from the
intervention.
We cannot assess how the refusal and withdrawal rates in
the current review compare with studies of other interventions
because papers do not consistently report refusal or withdraw-
al rates [80]. This is problematic, because there is no bench-
mark rate of refusal or withdrawal against which interventions
can be compared. Moreover, some reporting guidelines are
not as explicit as others, for example the Standards for Quality
Improvement Reporting Excellence (SQUIRE) guidelines do
not state that information relating to intervention acceptance
and withdrawal should be recorded [81], whereas the Consol-
idated Standards of Reporting Trials (CONSORT) guidelines
state that authors should report losses and exclusions after
randomization for each group, together with reasons [82].
Thus, to assess the generalizability and comparability of in-
terventions, all reporting guidelines should explicitly state the
need for clear and detailed reporting of participant refusals and
withdrawals [83]. Furthermore, uptake and withdrawal may
be impacted by the health status of the individual. For exam-
ple, patients who are very unwell and those who are relatively
well may not want to use telehealth because they think either
that they are too ill to use it or not ill enough, and therefore
refuse or abandon telehealth. Thus, papers need to report more
contextual information, such as health status, so that patients
can be compared with their counterparts. The majority of
papers included in the review were RCTs, where patient
withdrawal from interventions has been found to be lower
compared with practice [84]. RCTs are generally expensive
to conduct, and so patients who are believed to have the
ability and motivation to complete the intervention are
more likely to be selected to participate [85]. The RCT
studies included in the current review may therefore underes-
timate levels of abandonment compared with practice,
Table 3 Barriers to telehealth
Barrier Definition Paper number
Technology related Barriers relating to technology, which prevent patients
from using or makes it difficult to use telehealth
Technical problems Issues relating to equipment and technology, including:
difficulty connecting to system, equipment failure,
loss of data, usability challenges, and failed transmissions
2, 5, 7, 10, 12, 14, 23, 25,
26, 32, 34, and 37
Technology anxiety Tendency to feel hesitant, nervous or uneasy about using the
technological equipment
26, 27, and 34
Technical support Requiring assistance, to use or continue using technical
equipment
23 and 27
Telehealth process Barriers relating to the process of telehealth, which prevent
patients from using or makes it difficult to use telehealth
Believing telehealth to be
unnecessary
Not understanding the purpose of telehealth and considering
telehealth monitoring to be redundant, too invasive and
problematic for long term implementation
5, 17, 26, 28, and 29
Difficulty remembering Forgetting to interact with telehealth system and having to
be reminded
5, 17, and 23
Repetitive process Perceiving telehealth monitoring and content to be boring
or monotonous
17 and 35
Healthcare services Barriers to telehealth relating to access or use of services
delivering healthcare
Preference for in-person care Concern about the loss of personal contact with nurses,
feeling that some services could not be delivered via
telehealth, and finding face-to-face contact with healthcare
professionals important
7, 27, 34, and 35
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as they may have included people who were selected as being
more likely to complete the trial.
The review identified seven individual patient barriers to
telehealth acceptance and nine individual patient facilitators of
telehealth acceptance. Barriers and facilitators were identified
across all study designs; however, the majority of barriers and
facilitators were identified in the qualitative or mixed methods
studies. This is most likely explained by the fact that qualita-
tive studies are better able to identify patient reported barriers
and facilitators [86], as they tend to assess patient perceptions.
The most frequently reported barriers to telehealth were:
Technical problems, believing telehealth to be unnecessary,
and a preference for in-person care. Patients find it difficult to
use or understand technology and many experience technical
difficulties when using telehealth [87, 88]. These complaints
may be explained by the fact that according to a hospital
administrator, “people have a natural resistance to change
and patients are reluctant to try something new” [87]. Conse-
quently, patients often decide to decline or quickly abandon
telehealth, as a result of the technical problems that occur, or
are expected to occur. Patients also deem traditional commu-
nication via face-to-face contact between nurses and patients
to be more natural, free and unrestrained, as compared with
telehealth interactions [87, 89]. To overcome these patient
barriers to telehealth, it would be useful for healthcare profes-
sionals to ensure that patients, who are being offered
Table 4 Facilitators of telehealth
Facilitator Definition Paper number
Health management Facilitators of telehealth that relate to improved health or improved
management of health condition
Improved self-care Empowers patients to manage their health condition better, as it
makes them more careful and more concerned about their health.
It allows them to play a more active role in their health
management, thus leading to improvements in symptom
recognition and symptom management
1, 6–13, 16, 17, 20–24, 27, 29, 32,
33, and 35
Improved health knowledge Educates patient about their health, by providing more accurate
information in smaller pieces over time, which helps to reinforce
material, consequently giving patients a better understanding and
awareness of their condition
4, 5, 9–11, 13, 17, 21, 23, 27, 29, and
33
Effective health management Patients perceive telehealth to be a lifesaver, as it helps maintain
health stability and leads to improvements in patient clinical
outcomes. Plays a preventative role and diminishes potentially
negative health outcomes
5, 10, 13, 15–17, 27, 32, and 35
Healthcare services Facilitators of telehealth relating to access or use of services
delivering healthcare
Improved access to care Healthcare professionals are able to review the results of patient
self-testing immediately, and see any early warnings of health
status deterioration, thus reducing the number of emergency
department visits and hospital admissions
3, 5–7, 9, 10, 13–15, 21, 24, 27, and
32–35
Happy/confident in nurse advice Patients receive feedback and focused motivational support on
self-management from the nurses and the nurses are able to
address any problems patients have
5, 6, 7, 9, 15, and 23
As good/better than in-person care Care received through telehealth is seen to be as good as a visit
from the nurse and patients prefer to take their measurements
themselves at home, as they feel comfortable there
9, 13, 27, and 34
Patient variables Facilitators relating to patients’ beliefs about the benefits of telehealth
Convenient Telehealth is more useful and convenient than other methods of healthcare
delivery, as it takes very little time and does not interfere with usual
activities. Patients also benefit from decreased traveling, time saved,
and fewer medical visits
2, 5, 11, 12, 17, 21, 27, 32, and 35
Peace of mind (regarding health) Patients feel safer and more confident when participating in telehealth
monitoring. They are informed about their health status, and kept
regularly aware of the results, therefore they get to know whether
their body is functioning well, and do not worry about their health
as much
2, 6, 9, 10, 13, 26, 27, 32, 33, and 35
Technology-related Facilitators relating to technology, which make it easy for patients
to use telehealth
Ease of use Find working with the telehealth equipment to be not difficult at
all and verbalize that telehealth is not technologically intimidating
1, 2, 5, 11, 12, 16, 17, 20, 21, 22, 24,
and 27
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telehealth, understand why they are being asked to use it and
the benefits it can provide. Furthermore, the recent whole
systems demonstrator evaluation study found satisfaction with
telehealth equipment to be one of the main predictors of
continued participation in the whole systems demonstrator
trial [90]. Therefore, it would be advantageous to verify that
patients are able to use the telehealth equipment competently
and that any problems they encounter are resolved as quickly
as possible, to minimize negative perceptions. It may also be
useful for healthcare providers to offer telehealth to patients at
an earlier stage, to avoid patients becoming accustomed to in-
person visits from health professionals. However, both health
professionals and researchers should also be aware that
telehealth is not ideal for all patients and that some may never
want to use telehealth or be well enough to use the equipment.
The most frequently reported facilitators of telehealth were:
Improved self-care, increased access to healthcare, and im-
proved health knowledge. Patients think telehealth enables
them to better manage their health, by giving them better
physiological control [91–95]. Telehealth also increases pa-
tient health knowledge, as it gives them a better understanding
of their medical condition [96]. Patients also appreciate the
fact that telehealth can facilitate a quick response to any health
problems [65]. To improve uptake and sustained use, pro-
viders should consider communicating these facilitators of
telehealth to patients. Patients should be informed that
telehealth could help to educate them about their health con-
dition, lead to improved self-care and can also provide better
access to healthcare professionals.
In the current review, the quality of included studies was
assessed using the Critical Appraisal Skills Program critical
appraisal checklists, which address the key domains of meth-
odological quality. Despite several studies in the current re-
view having methodological weaknesses, there were no major
differences in the reporting of participant recruitment by all of
the 37 included studies, as compared with those reported by
the 11 high-quality studies. Participant refusal rates were
greater in the high-quality studies, as compared with the
moderate-quality studies; however only one high-quality
study reported the refusal rate for telehealth participants only,
in comparison to seven moderate-quality studies. Thus, it
could be argued that some of the studies which were regarded
as being high-quality were not actually that, but rather they
were written up in a high-quality way. Furthermore, almost all
of the barriers and facilitators that were identified as being the
most reported when including all studies regardless of meth-
odological quality were each reported in multiple high-quality
papers. Thus, it appears that the quality of the papers did not
have a major effect on the reported results with respect to the
barriers and facilitators of telehealth.
Healthcare professionals have a key role to play in patient
recruitment to telehealth interventions. Evidence would sug-
gest that, in research trials, frontline staff effectively screen
patients for whom they consider telehealth would be benefi-
cial [59]. For that reason, it is unknown how beneficial
telehealth would be for those patients who are informally
screened out, who decline it, or who drop out. Furthermore,
it is unknown whether there is any influence from clinical staff
over whether patients decide to accept or decline telehealth. A
recent systematic review by Brewster and colleagues [97]
concluded that frontline staff acceptance is essential, to im-
plement telehealth at scale. However, previous research has
found that some healthcare providers remain to be convinced
about telehealth. For example, some nurses are concerned that
telehealth would make them redundant and thus, they are
often less enthusiastic than patients in the initial phases of
telehealth implementation [35, 98–100]. Furthermore, the
RCN ehealth survey 2012 report found nursing staff that had
experience of telehealth were more likely to be positive about
it and to have more knowledge about the benefits than staff
with no experience of telehealth [101]. It would be valuable
for future research to investigate whether healthcare pro-
viders’ negative perceptions of telehealth could affect pa-
tients’ decisions to accept or decline telehealth [99].
To our knowledge, this is the first systematic review to
examine levels of home telehealth uptake and abandonment
and the factors that influence HF and/or COPD patients’
decisions to accept, refuse, or sustain using telehealth. A
potential limitation of the present review relates to the issue
of publication bias. For this review, we relied on the informa-
tion that was provided in published literature only, therefore,
we could have missed important gray literature. However, the
problem with gray literature is that some associations or
organizations can publish reports and working papers that
have their own political or social agendas, thus the validity
of evidence may be questionable as a result of selective
reporting [102]. Secondly, we excluded mobile phone-based
interventions because mobile-based systems are currently not
a mainstream means of delivering home telehealth. However,
mobile phones are increasingly taking the place of fixed-line
phones at home, and telehealth applications on mobile phones
look likely to become a viable alternative for home telehealth
in the future. A third limitation is that information has only
been obtained from research studies, where patients may have
been selected to participate on account of being more likely to
engage in sustained use of telehealth. Furthermore, the refusal
rates in these studies may be more representative of patients
refusing to take part in a trial, rather than refusing telehealth
per se. A fourth limitation is that it is difficult to differentiate
between the facilitators relating to uptake or sustained use, as
it is unknown whether the advantages of telehealth, specified
by patients, apply to their decision to accept or sustain using
telehealth.
The present review has consolidated current knowledge on
the rates of uptake, refusal, and sustained use of home
telehealth and has documented reasons for patient refusals
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and withdrawals from participation. It is evident that research
needs to report more detail relating to participant refusal and
withdrawal rates and their reasons for this. One explicit rec-
ommendation would be for future trials to report refusal rates
for both study participants and telehealth participants. The
review also identified an extensive range of barriers to, and
facilitators of, telehealth. Technical problems appeared to be a
major issue impacting on the uptake and sustained use of
telehealth, with studies reporting little tolerance for poorly
working systems, thus it is essential that telehealth equipment
is user friendly and functions effectively. Furthermore, users
can be unsure of the technology, hence appropriate training and
access to support could also support uptake and use. Compared
with quantitative studies, qualitative studies produced a wider
range of barriers to and facilitators of telehealth. Therefore,
further qualitative work is required [28], which will help to
explain the barriers and facilitators that currently lead to patient
uptake or refusal, and sustained use or abandonment, of
telehealth. Future research should also aim to understand the
role of clinical staff in how telehealth is offered and to consider
how this could impact on uptake. This future research will then
hopefully assist in the design of tools to predict which people
may be likely to take up and sustain using telehealth and those
for whom it would not be appropriate.
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